Ohno S - Search Results

1

Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.

Yamashiro H, Iwata H, Masuda N, Yamamoto N, Nishimura R, Ohtani S, Sato N, Takahashi M, Kamio T, Yamazaki K, Saito T, Kato M, Lee T, Kuroi K, Takano T, Yasuno S, Morita S, Ohno S, Toi M; JBCRG-C01 Collaborative Group. Yamashiro H, et al. Among authors: ohno s. Breast Cancer. 2020 Jul;27(4):631-641. doi: 10.1007/s12282-020-01057-4. Epub 2020 Feb 14. Breast Cancer. 2020. PMID: 32060785 Free PMC article.

2

Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer.

Tsutsui S, Ohno S, Murakami S, Hachitanda Y, Oda S. Tsutsui S, et al. Among authors: ohno s. Breast Cancer Res Treat. 2002 Jan;71(1):67-75. doi: 10.1023/a:1013397232011. Breast Cancer Res Treat. 2002. PMID: 11859875

3

Comparison of the immunohistochemical expression of EGFR, c-erbB2 and p53 protein between primary and recurrent breast cancer.

Tsutsui S, Ohno S, Murakami S, Kataoka A, Kinoshita J, Hachitanda Y. Tsutsui S, et al. Among authors: ohno s. Breast Cancer. 2002;9(2):111-7. doi: 10.1007/BF02967575. Breast Cancer. 2002. PMID: 12016390

4

Prognostic and predictive value of epidermal growth factor receptor in recurrent breast cancer.

Tsutsui S, Kataoka A, Ohno S, Murakami S, Kinoshita J, Hachitanda Y. Tsutsui S, et al. Among authors: ohno s. Clin Cancer Res. 2002 Nov;8(11):3454-60. Clin Cancer Res. 2002. PMID: 12429634

5

Brain metastasis of breast cancer.

Ohno S, Ishida M, Kataoka A, Murakami S. Ohno S, et al. Breast Cancer. 2004;11(1):27-9. doi: 10.1007/BF02967997. Breast Cancer. 2004. PMID: 14718788 Review. No abstract available.

6

Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer.

Morita S, Toi M, Kobayashi T, Ito Y, Hozumi Y, Ohno S, Iwata H, Sakamoto J. Morita S, et al. Among authors: ohno s. Jpn J Clin Oncol. 2004 Feb;34(2):104-6. doi: 10.1093/jjco/hyh016. Jpn J Clin Oncol. 2004. PMID: 15067105 Clinical Trial.

7

Fulvestrant for the treatment of advanced breast cancer in postmenopausal women: a Japanese study.

Watanabe T, Sano M, Ohno S, Inaji H, Nishimura R, Shin E, Nomura Y, Morris C. Watanabe T, et al. Among authors: ohno s. Anticancer Res. 2004 Mar-Apr;24(2C):1275-80. Anticancer Res. 2004. PMID: 15154660 Free article. Clinical Trial.

8

Combination chemotherapy with docetaxel and doxifluridine showed a beneficial outcome in advanced or recurrent breast cancer patients with longer disease-free interval.

Nishimura R, Tominaga T, Mitsuyama S, Aoyama H, Asaga T, Ohno S, Okuyama N, Kimura M, Iwase H, Kanda K, Koga T, Shiba E, Ikeda T. Nishimura R, et al. Among authors: ohno s. Anticancer Res. 2004 May-Jun;24(3b):2085-91. Anticancer Res. 2004. PMID: 15274405 Free article. Clinical Trial.

9

Sensitization of chemotherapy by anti-HER.

Kataoka A, Ishida M, Murakami S, Ohno S. Kataoka A, et al. Among authors: ohno s. Breast Cancer. 2004;11(2):105-15. doi: 10.1007/BF02968288. Breast Cancer. 2004. PMID: 15550854 Review.

10

Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.

Masuda TA, Kataoka A, Ohno S, Murakami S, Mimori K, Utsunomiya T, Inoue H, Tsutsui S, Kinoshita J, Masuda N, Moriyama N, Mori M. Masuda TA, et al. Among authors: ohno s. Int J Oncol. 2005 Mar;26(3):721-30. Int J Oncol. 2005. PMID: 15703829

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,944 results

Search Page

Filters